MULTIPLE SCLEROSIS-AYURVEDIC MANAGEMENT AND PREVENTIVE ASPECTS by Sasikumar, *Arjun & M, Aswathy
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
     IJAPR | August 2018 | Vol 6 | Issue 8  69 
International Journal of Ayurveda  
and Pharma Research 
 
Review Article 
 
MULTIPLE SCLEROSIS-AYURVEDIC MANAGEMENT AND PREVENTIVE ASPECTS 
Arjun Sasikumar1*, Aswathy M2 
*1Assistant Professor, Department of Panchakarma, Dharma Ayurveda Medical College and Hospital, 
Sriperumbudur, Tamil Nadu, India. 
2Senior Research Fellow, National Ayurveda Research Institute for Panchakarma, Cheruthuruthy, Kerala, India.  
ABSTRACT 
Multiple Sclerosis (MS) is a chronic progressive disease with a variety of cognitive, motor and 
sensory deficits. It is characterised by demyelination of axons of the brain and spinal cord where 
the patient presents with the complaints of blurred or double vision, lack of coordination, loss of 
balance, numbness and tremors throughout the body or extremities with weakness, muscle 
spasms etc. In Ayurveda, Multiple Sclerosis can be correlated to Snayusada or the aggravation of 
Vata in Snayu. Modern treatments like immunosuppressant, corticosteroids, stem cell therapy are 
highly expensive when compared to Ayurvedic management. The scope of Ayurvedic Management 
and preventive aspects mainly concentrates on improving the quality of life and decrease 
dependency of patients. The objective of this review is to evaluate the clinical utility of the 
Ayurvedic medicines for Multiple Sclerosis. Clinical trials by Ayurvedic experts suggest that 
Ayurvedic treatment processes and preventive measures (Life style management and 
recommended diet) may reduce the risk of Multiple Sclerosis. Here I briefly explain the current 
literature of Multiple Sclerosis, modern and Ayurvedic views, Ayurvedic medicines usually given in 
Multiple Sclerosis cases with a focus on designing prevention and treatment protocol. 
KEYWORDS: Multiple sclerosis, MS, Disease overview, Choice of drugs, Treatment, Preventive 
aspects, Snayusada. 
INTRODUCTION 
Ayurveda is ever green science and an art of 
life, where the healthy and ill alike, are more 
concerned with the maintenance and promotion of 
positive health as well as curing the diseases. The 
management criteria should be addressed to quality 
improvement in the life of patient, avoiding drug 
dependence and adverse effect. As far as Allopathic 
treatment is concerned, excess usage of cortico-
steroids make the MS patients more ill-health. 
Ayurveda offers the safe and effective form of 
therapy for Multiple Sclerosis. Still, MS symptoms can 
negatively affect quality of life. Suicide rates among 
patients with MS are higher than average. [1] So for 
improving the quality of life in MS patients, along 
with Ayurvedic therapies Psychological counselling 
should also be incorporated. 
Prevalence 
MS is the most common autoimmune 
disorder of the central nervous system. As of 2010, 
the number of people with MS was 2–2.5 million 
(approximately 30 per 100,000) globally, with rates 
varying widely in different regions. It is estimated to 
have resulted in 18,000 deaths that year. In Africa 
rates are less than 0.5 per 100,000, while they are 2.8 
per 100,000 in South East Asia, 8.3 per 100,000 in the 
Americans, and 80 per 100,000 in Europe. Rates 
surpass 200 per 100,000 in certain populations of 
Northern European descent. The number of new 
cases that develop per year is about 2.5 per 100,000. 
MS usually appears in adults in their late twenties or 
early thirties but it can rarely start in childhood and 
after 50 years of age. The primary progressive 
subtype is more common in people in their fifties. 
Similar to many autoimmune disorders, the disease is 
more common in women, and the trend may be 
increasing. As of 2008, globally it is about two times 
more common in women than in men. In children, it 
is even more common in females than males, while in 
people over fifty, it affects males and females almost 
equally.[2] 
Disease Overview 
Modern view 
Multiple Sclerosis is characterized by chronic 
inflammation and selective destruction of CNS 
myelin; peripheral nervous system is spared. 
Pathologically, the multifocal scarred lesions of MS 
are termed plaques. Etiology is thought to be auto 
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immune, with susceptibility determined by genetic 
and environmental factors. 
Clinical features: Onset may be abrupt or insidious. 
Some patients have symptoms that are so trivial that 
they may not seek medical attention for months or 
years. Most common are recurrent attacks of focal 
neurologic dysfunction, typically lasting weeks or 
months, and followed by variable recovery; some 
patients initially present with slowly progressive 
neurologic deterioration. Symptoms often transiently 
worsen with fatigue, stress, exercise or heat. 
Manifestations of MS are protean but commonly 
include weakness and/or sensory symptoms 
involving a limb, visual difficulties, abnormalities of 
gait and coordination, urinary urgency or frequency, 
and abnormal fatigue. Motor involvement can 
present as a heavy, stiff, weak, or clumsy limb. 
Localized tingling, “pins and needles”, and “dead” 
sensations are common. Optic neuritis can result in 
blurring of vision, especially in the central visual 
field, often associated retro-orbital pain accentuated 
by eye movement. Involvement of the brainstem may 
result in diplopia, nystagmus, vertigo, or facial pain, 
numbness, weakness, hemi spasm, or myokymia 
(rippling muscular contractions). Ataxia, tremor, and 
dysarthria may reflect disease of cerebellar 
pathways. Lhermitte’s symptom, a momentary 
electric shock-like sensation evoked by neck flexion, 
indicates disease in the cervical spinal cord.[3] 
Neurologists agree that patients may be 
grouped into four major categories based on the 
course of disease[4]: 
1. Relapsing-remitting MS: The most common form, 
affecting about 85% of MS patients. It is marked 
by flare-ups (relapses or exacerbations) of 
symptoms followed by periods of remission, 
when symptoms improve or disappear. 
2. Primary progressive MS: affects approximately 
10% of MS patients. Symptoms continue to 
worsen gradually from the beginning. There are 
no relapses or remissions, but there may be 
occasional plateaus. This form of MS is more 
resistant to the drugs typically used to treat the 
disease. 
3. Secondary progressive MS: may develop in some 
patients with relapsing–remitting disease. For 
many patients, treatment with disease-modifying 
agents helps delay such progression. The disease 
course continues to worsen with or without 
periods of remission or leveling off of symptom 
severity (plateaus). 
4. Progressive-relapsing MS: a rare form, affecting 
fewer than 5% of patients. It is progressive from 
the start, with intermittent flare-ups of 
worsening symptoms along the way. There are no 
periods of remission. 
A study was conducted on Therapeutic exercises for 
those moderately affected with MS in the School of 
Medicine, University of Glasgow. Three consecutive 
studies were conducted by the author. In the first 
study, a 12-week therapeutic exercise was delivered 
to twenty people with MS, whilst 12 people acted as 
control groups who received usual care. Clinical 
outcomes were assessed at five time points over the 
intervention and 12 month follow up period of the 
study. The results were not statistically significant, 
however the calculated effect indicated positive 
effects on areas related to physiological (strength, 
fatigue), functional (mobility, balance and daily 
activities) and psychological status of participants. In 
the second study, three inter-related themes 
emerged. [a] Exercise class, which developed a bridge 
to allow participants to realize [b] Benefits of the 
class, helping them to overcome [c] Barriers to 
exercise. The result suggested that benefits to 
participating in exercise and the exercise 
intervention included social support and symptom 
improvement. Barriers to exercise included 
perceived psychological factors, symptoms and lack 
of service. In the third study, test re-test reliability of 
four outcome measures used in the first study, 
calculations were done to establish the clinically 
significant change and precision of the outcome 
measures. The test re-test reliability of the outcome 
measures was good, with the calculated clinical 
change and precision of the outcome measures in 
those moderately affected with MS highlighting the 
problems of assessing those with MS.[5] 
Ayurvedic view 
In Ayurvedic system this may be considered as 
Snayusadam with Nadibalakshayam. As per some 
expert’s opinion, we have to consider this as 
Vatavikaram with Nadisadam. Ultimately the Dhatus 
get damaged. Demyelination indicates 
 Majjadhatukshayam[6]- Decreased Majja causes 
Asthisoushirya (osteoporosis), Bhrama (giddiness) 
and Timiradarshana (dimness of vision). 
 Kaphakshayam[7]- Decreased Kapha causes 
Bhrama, empty feeling of Sleshmakshaya (Kapha 
depots in the body), Hridrava (palpitation) and 
Sandhishaithilya (laxity of joints). 
 Ojakshayam[8]- Decreased Oja is due to anger, 
hunger, constant thinking, grief, exertion etc. 
leading to phobias, loss of strength, excessive 
thoughts, sensory disturbances, loss of 
complexion, confusion, increased dryness of the 
body and exhaustion. 
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All the above symptoms are commonly seen in MS 
patients. Here the treatment should be for Vata 
samana and Nadidyothaka. 
Choice of drugs in MS cases 
 Dhanadanayanadikashayam-Indicated in Arditha 
and Akshepaka Vata conditions. 
 Bhadradarvadikashayam-Indicated in Painful 
conditions, Kevala vata. 
 Dhanwantharamkashayam-Indicated in 
Neurological and Rheumatic problems. 
 Dasamoolamkashayam-Indicated in vitiated Vata 
kapha condition. 
All these Kashayams according to the symptoms 
of MS patients can be given with adjuvants like 
Ksheerabalaavarthi, milk, Dhanwantharigulika. 
Single drugs for intake as Choornam or 
Palkashayam (milk decoction) 
 Ashwagandha 
 Jeevanthi 
 Guduchi 
 Yashtimadhu 
 Vidari 
Treatment procedures 
1. In MS cases prime importance goes to 
Snehapanam with Rasnadi ghritha/Jeevantyadi 
ghritha/ Vidaryadighritha (After Snehapana, if the 
patient seems to be Kapha dominant in nature and 
pravarasatwa we can conduct Vamanakriya, 
especially in Avarana Vata cases). 
2. Shirodhara with Rasnaditaila/ Mahamashataila/ 
Ksheerabalataila. 
3. Ksheeradhara with Dasamoola+ Ashwagandha 
ksheerapaka. 
4. Thalamwith Jeevanthyadichoornam/ Vidaryadi 
choornam + Ksheerabala/ Sahacharadi 3 Avarthi. 
5. Akshitarpanam with Triphala ghritha/ 
Jeevanthyadighrita. This treatment procedure is 
adopted for the complaints of blurred vision in MS 
cases. 
6. Ksheeravasthi[9] 
A study on the effect of Ayurvedic and 
Panchakarma Treatment in MS has shown significant 
improvement in pain, weakness and power loss. In 
that study, a 35 year old female presented with the 
complaints of pain, burning, stiffness and complete 
weakness (MPG zero grade) in lumbar region, loss of 
bowel control for 18 months. She was a diagnosed 
case of Multiple Sclerosis (Kurtzke Disability Grade 
eight). Ayurvedic correlation given to this case was 
Asthi-Majjagatavata. This patient was given internal 
medications like powders of Ashwagandha and 
Shatavari (each 5gms) along with 1 glass warm milk, 
Chandraprabhavati (500mg) twice daily before food. 
Mahayogarajaguggulu (500mg.) is given with 
Ashwagandh-arishta (30ml) twice daily after food. 
The external therapies done for the patient was 
Sarvanga Abhyanga with Bala Taila and followed by 
Shashtika Shalipinda sweda. Patient also received two 
types of basthi. Initially patient received Matrabasthi 
for 26 days followed by Yapanabasthi for 17 days. 
After 15 weeks of I.P treatment, the patient was 
discharged. She was advised to continue oral 
medications and application of external oil for 2 
months. After the first two weeks of I.P treatment, the 
patient had shown mild reduction in burning 
sensation, pain and stiffness of lower extremities but 
other symptoms were as such. After 1 month, there 
was moderate reduction in pain and stiffness of 
lower extremities. During the second month of I.P 
treatment, pain and stiffness in both lower 
extremities were very mild. Muscular power also 
improved to second grade. At the time of discharge, 
patient did not suffer from pain and stiffness of lower 
extremities. Muscle power improved to third grade. 
She could walk to 30meters with the help of crutches. 
Kurtzke EDSS score reduced to 6.5 indicating 
requirement of constant bilateral assistance (canes, 
crutches, and braces) and can walk about 20meters 
with outresting [10]. 
On the basis of Physician’s Yukthi and 
patient’s condition medicines should be selected for 
doing therapy. Over use of Ushna and Snigdha guna 
are found to be having Anupashaya especially ushna 
promotes degeneration. Along with the treatment 
schedule advise therapeutic Yoga, Pranayama, 
meditation etc. These have predominant benefits in 
the results. 
Preventive aspects of MS 
Preventive aspects of Multiple Sclerosis are 
mainly aimed at arresting or slowing down the 
progress of the illness and avoiding symptoms. 
Diet recommendations for Multiple Sclerosis 
1. Take a balanced wholesome diet. 
2. Eat organic food and totally avoid processed food. 
3. For cooking purpose, use olive oil or coconut oil. 
4. Snacks in between main meals should consist of 
fresh fruits, green leafy salads, legumes and nuts. 
5. The best immune boosters include sweet potatoes, 
carrots, pineapple, papaya, mango, guava, banana, 
grape, hazel nut, walnut, apple, cashew, kidney 
beans, green beans, lentils, yogurt, avocado, 
pumpkin, garlic, ginger, spinach, oats, wheat germ, 
turmeric, safflower oil. 
6. Avoid Caffeine, Smoking and Alcohol which all 
affects the nervous system. 
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Lifestyle recommendations for Multiple Sclerosis 
1. Start the day with a glass of luke warm water as 
soon as you leave your bed. Drink 8 to 10 glasses 
of fresh water in a day. 
2. Do all measures to reduce stress. Find best stress 
reducing activities like Yoga, Tai chi, Meditation 
or self-hypnosis and practice them regularly to 
manage stress and reduce your pains. 
3. Sleep regularly: Sleep for at least seven hours 
each night so that your mind can be refreshed 
and your body can have the time it needs to 
repair tissues and joints.  
4. Manage your time. Fatigue is a common sign of 
MS. So there are chances that you will try to 
complete too much work when you are feeling 
well. It will leave you feeling even more fatigued 
and stressed afterwards. Try to pace yourself. 
5. Maintain a healthy weight. Obesity can cause 
inflammation in the body, which can activate the 
immune system leading to progression of MS. 
CONCLUSION 
In summary, the current evidence of the 
Ayurvedic clinical trials suggests that Ayurvedic 
treatments, life style and dietary modifications plays 
a key role in MS prevention and provide increased 
life expectancy. Both Ayurvedic and modern 
knowledge should be incorporated to execute a 
better treatment protocol. More researches are 
required in this field to describe further more 
treatments in patients with MS and their clinical 
utility has to be established. 
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